French QASCI questionnaire for caregivers of people with COPD
Official title: Validation of the French Version of the Informal Caregiver Burden Assessment Questionnaire (QASCI) in Caregivers of Patients With COPD (VALQASCI)
Run by University Hospital, Brest · NCT06652204 · Data updated 2026-11-12
This project will test the French version of the QASCI questionnaire to see if it works well for caregivers of people with COPD.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 224 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 2 sites (Brest and 1 other locations) |
| Status | Recruiting |
| Started | October 22, 2024 |
| Main results expected | June 15, 2026 |
| Study ends | June 15, 2026 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT06652204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adult (18+) family caregivers or household members of a patient with COPD in stable condition who can read and complete French questionnaires and who provide non-opposition to participate.
✕Probably not a fit
Caregivers who cannot complete French questionnaires, who are under judicial protection, whose patient had a recent exacerbation, or who care for patients with cognitive impairment are excluded and therefore unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational validation project adapts and tests the Portuguese QASCI questionnaire in French-speaking caregivers of patients with COPD. Caregivers who meet inclusion criteria will complete the French QASCI and related measures at participating centers in Brittany. The study will examine linguistic and cultural fit and use standard psychometric analyses (reliability, internal consistency, and construct validity) to determine whether the translated questionnaire performs acceptably. Recruitment and data collection occur at the University Hospital of Brest and the Centre Hospitalier de Morlaix.
Why it matters
Potential benefit: If successful, clinicians and researchers will have a validated French tool to measure caregiver burden and better target support services.
How similar studies have gone: The QASCI was originally validated in Portuguese (Hipolito et al.) and has been used in other language adaptations, so this is a linguistic and cultural validation of an established instrument rather than a wholly novel concept.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being a caregiver of a relative with COPD (according to the GOLD criteria). * Being 18 years old or older. * The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month). * Being a family member of the patient or living with the patient. * Being able to complete the French questionnaires. * Non-opposition statement provided. NON-INCLUSION CRITERIA * Person under judicial protection (guardianship, curatorship, etc.) * Refusal to participate * The patient under the caregiver's care has experienced an exacerbation in the previous month * The caregiver reports that the patient has cognitive impairments.
Where it's running
-
Chu Brest
Brest, France Recruiting -
Centre hospitalier de Morlaix
Morlaix, France Recruiting
Study contacts
- Principal investigator: Marc Beaumont, PhD — Centre Hospitalier des Pays de Morlaix
- Study coordinator: Marc BEAUMONT, PhD
- Email: mbeaumont@ch-morlaix.fr
- Phone: +33 298626160
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.